Literature DB >> 10872872

Differential effect of TPA on cell growth and Epstein-Barr virus reactivation in epithelial cell lines derived from gastric tissues and B cell line Raji.

M Kanamori1, M Tajima, Y Satoh, Y Hoshikawa, Y Miyazawa, K Okinaga, T Kurata, T Sairenji.   

Abstract

We characterized the cell growth and Epstein-Barr virus (EBV) reactivation for EBV infected epithelial cell lines, GT38, GT39, and GTC-4 using 12-O-tetradecanoylphorbol-13-acetate (TPA). These cell lines grew similarly in liquid medium, and formed colonies in soft agar. The cell growth was inhibited with TPA, dose-dependently in liquid medium. The colony formation was enhanced with low concentrations of TPA, but was inhibited with high concentrations. The latent EBV was reactivated with high concentrations of TPA as shown by the expression of EBV BZLF1 gene product ZEBRA. The effects of TPA on GTC-4 were compared with a Burkitt's lymphoma cell line Raji. The mode of actions of TPA in GTC-4 was different from Raji in terms of cell growth and EBV reactivation. The effective concentrations of TPA for cell growth inhibition and EBV reactivation were higher in Raji than GTC-4. Cell cycle analysis showed that TPA (20 ng/ml) induced cell cycle arrest to Raji but not to GTC-4; however, the rate of trypan blue stained cells increased in the TPA treated GTC-4 but not Raji. These results demonstrated that TPA affects differentially for the stimulation and inhibition of cell growth, and also EBV reactivation depends on TPA concentrations and cell types.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10872872     DOI: 10.1023/a:1008110312661

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  32 in total

1.  TPA induction of Epstein-Barr virus early antigens in Raji cells is blocked by selective protein kinase-C inhibitors.

Authors:  J Lazdins; C Zompetta; S Grimaldi; G Barile; M Venanzoni; L Frati; A Faggioni
Journal:  Int J Cancer       Date:  1987-12-15       Impact factor: 7.396

2.  Epstein-Barr virus in synergy with tumor-promoter-induced malignant transformation of immortalized human epithelial cells.

Authors:  B M Li; Z W Ji; Z S Liu; Y Zeng
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

3.  Synchronous and sequential activation of latently infected Epstein-Barr virus genomes.

Authors:  K Takada; Y Ono
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

4.  Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: activation of transforming growth factor beta igh3 (TGF-beta igh3) and TGF-beta 1.

Authors:  C Cayrol; E K Flemington
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

5.  Hybridization between a human epithelial line, infectable by Epstein-Barr virus, and Burkitt lymphoma lines: membrane properties, superinfectability, inducibility and tumorigenicity.

Authors:  S Mitrani-Rosenbaum; R Ber; N Goldblum; S Povey; H Gamliel; H Ben-Bassat
Journal:  Int J Cancer       Date:  1982-11-15       Impact factor: 7.396

6.  Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1.

Authors:  E Flemington; S H Speck
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

7.  Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GT38 and GT39) derived from gastric tissues.

Authors:  N Takasaka; M Tajima; K Okinaga; Y Satoh; Y Hoshikawa; T Katsumoto; T Kurata; T Sairenji
Journal:  Virology       Date:  1998-08-01       Impact factor: 3.616

8.  Epstein-Barr virus in gastric carcinoma.

Authors:  M Tokunaga; C E Land; Y Uemura; T Tokudome; S Tanaka; E Sato
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

9.  Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism.

Authors:  S Zalani; E Holley-Guthrie; S Kenney
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

10.  Colonies of EBNA-positive cells in soft agar from peripheral leukocytes of infectious mononucleosis patients.

Authors:  Y Hinuma; T Katsuki
Journal:  Int J Cancer       Date:  1978-04-15       Impact factor: 7.396

View more
  7 in total

Review 1.  Herpesvirus lytic replication and the cell cycle: arresting new developments.

Authors:  E K Flemington
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Functional role of phosphatidylinositol 3-kinase/Akt pathway on cell growth and lytic cycle of Epstein-Barr virus in the Burkitt's lymphoma cell line, P3HR-1.

Authors:  Takako Mori; Takeshi Sairenji
Journal:  Virus Genes       Date:  2006-06       Impact factor: 2.332

3.  Transcriptional repression by sumoylation of Epstein-Barr virus BZLF1 protein correlates with association of histone deacetylase.

Authors:  Takayuki Murata; Naoe Hotta; Shigenori Toyama; Sanae Nakayama; Shigeki Chiba; Hiroki Isomura; Takayuki Ohshima; Teru Kanda; Tatsuya Tsurumi
Journal:  J Biol Chem       Date:  2010-06-01       Impact factor: 5.157

4.  TORC2, a coactivator of cAMP-response element-binding protein, promotes Epstein-Barr virus reactivation from latency through interaction with viral BZLF1 protein.

Authors:  Takayuki Murata; Yoshitaka Sato; Sanae Nakayama; Ayumi Kudoh; Satoko Iwahori; Hiroki Isomura; Masako Tajima; Takayuki Hishiki; Takayuki Ohshima; Makoto Hijikata; Kunitada Shimotohno; Tatsuya Tsurumi
Journal:  J Biol Chem       Date:  2009-01-21       Impact factor: 5.157

5.  Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication.

Authors:  Ayumi Kudoh; Masatoshi Fujita; Tohru Kiyono; Kiyotaka Kuzushima; Yutaka Sugaya; Shunji Izuta; Yukihiro Nishiyama; Tatsuya Tsurumi
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma.

Authors:  Susanna Mannucci; Anna Luzzi; Alessandro Carugi; Alessandro Gozzetti; Stefano Lazzi; Valeria Malagnino; Monique Simmonds; Maria Grazia Cusi; Lorenzo Leoncini; Cornelia A van den Bosch; Giulia De Falco
Journal:  Adv Hematol       Date:  2012-04-24

7.  Chlorpyrifos Induces the Expression of the Epstein-Barr Virus Lytic Cycle Activator BZLF-1 via Reactive Oxygen Species.

Authors:  Ling Zhao; Fei Xie; Ting-ting Wang; Meng-yu Liu; Jia-la Li; Lei Shang; Zi-xuan Deng; Peng-xiang Zhao; Xue-mei Ma
Journal:  Oxid Med Cell Longev       Date:  2015-07-14       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.